HCA Healthcare (HCA)
(Delayed Data from NYSE)
$388.78 USD
+5.66 (1.48%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $388.78 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
A Value B Growth D Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HCA 388.78 +5.66(1.48%)
Will HCA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HCA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HCA
Ensign Group (ENSG) Up 50% in Past Year: More Growth on the Horizon?
Why Is Tenet (THC) Up 7.2% Since Last Earnings Report?
HCA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Medical Stocks Lagging Athira Pharma (ATHA) This Year?
Why Is HCA (HCA) Up 9.5% Since Last Earnings Report?
Taiwan Semiconductor and Cars.com have been highlighted as Zacks Bull and Bear of the Day
Other News for HCA
Hamilton ETFs Announces August 2024 Cash Distributions
HCA Healthcare price target raised by $27 at RBC Capital, here's why
Franklin Equity Income Fund Q2 2024 Commentary
HCA Healthcare price target raised by $40 at Truist, here's why
Analysts Are Bullish on These Healthcare Stocks: Progyny (PGNY), HCA Healthcare (HCA)